May 16, 2025
Two-thirds of pregnant individuals opted for either maternal vaccination against RSV or for neonatal monoclonal antibody therapy and for other vaccines recommended in pregnancy.
May 16, 2025
A preview of sessions covering menopause and vasomotor symptoms during ACOG 2025 in Minneapolis, MN.
May 16, 2025
In a cancer survivorship clinic in urban New York, only one-quarter of long-term breast cancer survivors received genetic testing, contrary to current recommendations.
May 16, 2025
Secnidazole granules reduced recurrence rates to 20% over a period of 28 weeks in a small prospective pilot study, outperforming cumbersome daily regimens.
May 15, 2025
The most commonly reported adverse effects of high-dose glucocorticoid therapy were on bone health, cardiometabolic function, and height and growth.
May 14, 2025
The potential cardiovascular impact of prolonged oral corticosteroid therapy in the AD population observed in this study confirms longstanding cautions.
May 14, 2025
Semaglutide was associated with a significant reduction in risk for major adverse cardiovascular events after just 3 months of treatment in a population with established CVD.
May 13, 2025
Medical and nonpharmacologic treatment options for VMS range in efficacy and risk/benefit profile; a short slide show offers a topline look at how many compare.
May 13, 2025
Hot flashes and night sweats are just 2 of the myriad symptoms associated with menopause. Click through a quick refresher on the transition and effective treatments.
May 13, 2025
Semaglutide dosing was individually tailored for adults with obesity and supported with app-based coaching on diet, physical activity, and other lifestyle factors.